$AMLX 8-K SEC Filings

Filed On	Filing
08 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 8, 2026, Amylyx Pharmaceuticals, Inc. (the “Company”) entered into a Manufacturing and Supply Agreement (the “Bachem Manufacturing Agreement”) with Bachem Americas, Inc. (“Bachem”) and on September 1, 2026, the Company enter...
20 Aug 2026	8-K: Entry into a Material Definitive Agreement
18 Aug 2026	8-K: Other Events
18 Aug 2026	8-K: Regulation FD Disclosure; Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
24 Mar 2026	8-K: Regulation FD Disclosure
03 Mar 2026	8-K: Results of Operations and Financial Condition
08 Jan 2026	8-K: Regulation FD Disclosure; Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
10 Sep 2025	8-K: Entry into a Material Definitive Agreement
27 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
05 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
04 Mar 2025	8-K: Results of Operations and Financial Condition
10 Jan 2025	8-K: Entry into a Material Definitive Agreement
30 Dec 2024	8-K: Regulation FD Disclosure
07 Nov 2024	8-K: Results of Operations and Financial Condition

Comments